Vascular access in children on chronic hemodialysis: a Slovenian experience

Rina R Rus1, Gregor Novljan, Jadranka Buturović-Ponikvar

  • 1Department of Pediatric Nephrology, University Medical Center, Ljubljana, Slovenia. rina.rus@guest.arnes.si

Insights

Arteriovenous fistulas (AVFs) are preferred for pediatric hemodialysis, but non-cuffed central venous catheters (CVCs) are a viable alternative when AVFs are not feasible. Both vascular access methods were evaluated in children with end-stage renal disease.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Pediatrics

Background:

  • End-stage renal disease (ESRD) necessitates hemodialysis (HD) in children and adolescents.
  • Vascular access is crucial for effective HD treatment in pediatric patients.
  • Arteriovenous fistulas (AVFs) and central venous catheters (CVCs) are common vascular access modalities.

Purpose of the Study:

  • To evaluate the experience with arteriovenous fistulas (AVFs) and non-cuffed central venous catheters (CVCs) in pediatric patients undergoing hemodialysis.
  • To compare the efficacy and complication rates of AVFs and CVCs in children with end-stage renal disease.
  • To determine the suitability of these vascular accesses for long-term hemodialysis in a pediatric population.

Main Methods:

  • Retrospective study of pediatric patients (≤18 years) with ESRD on HD between December 1998 and December 2010.
  • Data collection on the creation, use, and outcomes of 35 AVFs and 77 non-cuffed CVCs.
  • Analysis of primary failure rates, maturation times, patency, and bacteremia incidence.

Main Results:

  • AVFs had a primary failure rate of 25.7%, with a mean maturation time of 4.0 months and mean patency of 42.5 months.
  • Non-cuffed CVCs, primarily inserted in the jugular vein with citrate locking, had a bacteremia incidence of 0.9 episodes per 1000 catheter days.
  • CVCs were used for an average of 3.6 months.

Conclusions:

  • Native AVFs are the preferred vascular access for pediatric hemodialysis.
  • Non-cuffed, jugular vein CVCs with citrate locking can serve as acceptable long-term vascular access when AVFs are not possible.
  • Careful consideration of vascular access type is essential for optimizing hemodialysis outcomes in children with ESRD.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...